We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$677M
AUM Growth
-$50M
(-6.9%)
Cap. Flow
-$67.1M
Cap. Flow
% of AUM
-9.92%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,031
New
439
Increased
126
Reduced
146
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.2M |
| 2 |
Kimberly-Clark
KMB
|
+$8.57M |
| 3 |
SBA Communications
SBAC
|
+$7.81M |
| 4 |
PG&E
PCG
|
+$5.73M |
| 5 |
Advance Auto Parts
AAP
|
+$5.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$15.6M |
| 2 |
Pfizer
PFE
|
+$14.6M |
| 3 |
Dominion Energy
D
|
+$13.4M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.9M |
| 5 |
Cadence Design Systems
CDNS
|
+$9.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.25% |
| 2 | Technology | 16.12% |
| 3 | Industrials | 11.55% |
| 4 | Financials | 11.01% |
| 5 | Healthcare | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Seres Therapeutics
MCRB
$48.9M
| $53.2K | 0.01% |
+556
| New | +$60.5K |
|
|
CHMI
702
Cherry Hill Mortgage Investment Corp
CHMI
$88.5M
| $49.5K | 0.01% |
+10,242
| New | +$52.7K |
|
|
SVM
703
Silvercorp Metals
SVM
$2.53B
| $47.5K | 0.01% |
+16,850
| New | +$57.3K |
|
704
ThredUp
TDUP
$422M
| $44.7K | 0.01% |
+18,321
| New | +$48K |
|
|
SOL
705
DELISTED
Emeren Group
SOL
| $43K | 0.01% |
+11,336
| New | +$44K |
|
706
Altimmune
ALT
$599M
| $41.3K | 0.01% |
+11,712
| New | +$52.6K |
|
707
IAMGOLD
IAG
$10.5B
| $36.9K | 0.01% |
+14,040
| New | +$40.6K |
|
708
Conduent
CNDT
$264M
| $35.2K | 0.01% |
+10,347
| New | +$33.9K |
|
709
Douglas Elliman
DOUG
$162M
| $34K | 0.01% |
+15,330
| New | +$42.1K |
|
710
Solid Power
SLDP
$532M
| $33.4K | ﹤0.01% |
13,161
-10,459
| -44% | -$24.1K |
|
711
FuelCell Energy
FCEL
$1.63B
| $29.1K | ﹤0.01% |
+449
| New | +$30.5K |
|
|
AAT
712
American Assets Trust
AAT
$1.4B
| – | – |
-15,014
| Closed | -$279K |
|
713
Albertsons Companies
ACI
$5.83B
| – | – |
-118,599
| Closed | -$2.46M |
|
714
Axcelis
ACLS
$4.33B
| – | – |
-9,481
| Closed | -$1.26M |
|
715
Aecom
ACM
$9.75B
| – | – |
-17,224
| Closed | -$1.45M |
|
716
Adient
ADNT
$1.5B
| – | – |
-5,371
| Closed | -$220K |
|
717
Automatic Data Processing
ADP
$108B
| – | – |
-6,897
| Closed | -$1.54M |
|
718
ADT
ADT
$5.58B
| – | – |
-31,468
| Closed | -$228K |
|
|
AEVA
719
Aeva Technologies
AEVA
$1.86B
| – | – |
-3,313
| Closed | -$19.7K |
|
720
Aflac
AFL
$62.6B
| – | – |
-11,404
| Closed | -$736K |
|
721
AGNC Investment
AGNC
$12.9B
| – | – |
-66,454
| Closed | -$670K |
|
|
AIV
722
Aimco
AIV
$383M
| – | – |
-10,202
| Closed | -$78.5K |
|
723
Assurant
AIZ
$14.3B
| – | – |
-9,433
| Closed | -$1.13M |
|
724
Akamai
AKAM
$15.9B
| – | – |
-24,694
| Closed | -$1.93M |
|
725
Albemarle
ALB
$15.5B
| – | – |
-21,579
| Closed | -$4.77M |
|
Similar funds
SA
WCM
PFPGI
PG
SI
MA
TCM
HBWM
Aigen Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Aigen Investment Management held 1,031 positions worth $677M, down 6.9% from $727M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Aigen Investment Management withdrew a net $67.1M in Q2 2023, closing 320 positions and reducing 146 holdings. Its most notable exit was Pfizer, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aigen Investment Management opened a new position in Apple worth $11.4M.
- Aigen Investment Management's largest Q2 2023 buy was Apple: 58,654 shares worth $11.4M.
- Aigen Investment Management added most to Advance Auto Parts in Q2 2023, an estimated $5.62M increase.
- Aigen Investment Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $15.6M.
- Aigen Investment Management fully exited Pfizer in Q2 2023, selling an estimated $14.6M.
- Aigen Investment Management's ten largest holdings make up 11% of its $677M portfolio in Q2 2023.
- Aigen Investment Management opened 439 new positions and closed 320 in Q2 2023.
- Aigen Investment Management's portfolio value fell 6.9% quarter-over-quarter to $677M.
Based on Aigen Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.